IPILIMUMAB IN THERAPY OF METASTATIC MELANOMA

Metastatic melanoma remains a refractory disease. Great progress in therapy of metastatic melanoma patients has been made in the recent five years. Targeted immunotherapy – a selective effect on lymphocytes signal molecules - became a principally new trend in the drug therapy of tumors. Ipilimumab i...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: I. V. SAMOILENKO, G. Y. KHARKEVICH, L. V. DEMIDOV
Fformat: Artigo
Iaith:Russo
Cyhoeddwyd: Remedium Group LLC 2016-12-01
Cyfres:Медицинский совет
Pynciau:
metastatic melanoma
immunooncology
anti-ctla4
ipilimumab
Mynediad Ar-lein:https://www.med-sovet.pro/jour/article/view/1409
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg